share_log

康方生物：委任首席財務官

AKESO: APPOINTMENT OF CHIEF FINANCIAL OFFICER

HKEX ·  Jul 22 08:15

Summary by Futu AI

康方生物科技（開曼）有限公司於2024年7月22日宣布，王秉中博士（Bing C. WANG）已被委任為公司的首席財務官。王博士在生物製藥領域具有豐富的全球化戰略投資、公司融資、財務管理和企業發展經驗。他曾在Cellectis S.A.擔任首席財務官，並是Refuge Biotechnologies, Inc.的聯合創始人兼首席執行官。此外，王博士也在巴克萊資本的美國醫療健康投行部擔任過董事，並是哥倫比亞商學院醫療健康與製藥管理項目諮詢委員會的成員。他擁有哥倫比亞大學和普林斯頓大學的學位。康方生物的董事會對王博士的加入表示熱烈歡迎，並期待他為公司的願景和使命作出貢獻。
康方生物科技（開曼）有限公司於2024年7月22日宣布，王秉中博士（Bing C. WANG）已被委任為公司的首席財務官。王博士在生物製藥領域具有豐富的全球化戰略投資、公司融資、財務管理和企業發展經驗。他曾在Cellectis S.A.擔任首席財務官，並是Refuge Biotechnologies, Inc.的聯合創始人兼首席執行官。此外，王博士也在巴克萊資本的美國醫療健康投行部擔任過董事，並是哥倫比亞商學院醫療健康與製藥管理項目諮詢委員會的成員。他擁有哥倫比亞大學和普林斯頓大學的學位。康方生物的董事會對王博士的加入表示熱烈歡迎，並期待他為公司的願景和使命作出貢獻。
On July 22, 2024, Akeso (Cayman) Limited announced that Dr. Bing C. Wang has been appointed as the company's Chief Financial Officer. Dr. Wang has extensive experience in global strategic investment in the biopharmaceutical field, corporate financing, financial management, and business development. He previously served as the Chief Financial Officer of Cellectis S.A. and was a co-founder and CEO of Refuge Biotechnologies, Inc. In addition, Dr. Wang has also served as a director in the healthcare investment banking division of Barclays Capital USA and is a member of the Columbia Business School Healthcare and Pharmaceutical Management Program Advisory Committee. He holds degrees from Columbia University and Princeton University. The board of directors of Akeso warmly welcomes Dr. Wang's joining and looks forward to his contribution to the company's vision and mission.
On July 22, 2024, Akeso (Cayman) Limited announced that Dr. Bing C. Wang has been appointed as the company's Chief Financial Officer. Dr. Wang has extensive experience in global strategic investment in the biopharmaceutical field, corporate financing, financial management, and business development. He previously served as the Chief Financial Officer of Cellectis S.A. and was a co-founder and CEO of Refuge Biotechnologies, Inc. In addition, Dr. Wang has also served as a director in the healthcare investment banking division of Barclays Capital USA and is a member of the Columbia Business School Healthcare and Pharmaceutical Management Program Advisory Committee. He holds degrees from Columbia University and Princeton University. The board of directors of Akeso warmly welcomes Dr. Wang's joining and looks forward to his contribution to the company's vision and mission.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated